News

Hear from NIH Tech Transfer Experts at BioTechX. From Partnering with NIH in the Rare Disease Landscape to Leveraging NIH as Your Commercialization Partner: Learn from some of the best at BioTechX 2025! Steve Ferguson, NIH Office of Technology Transfer. Joseph Conrad, NIH National Cancer Institute.

Hear from Two NIH Tech Transfer Experts at BioTechX

Two NIH Technology Transfer experts are headed to Philadelphia for the BioTechX conference taking place September 16-17, 2025. Steve Ferguson, Special Advisor in the NIH Office of Technology Transfer will be speaking on the Partnering with NIH in the Rare Disease Landscape panel on September 16th
More
blank new placeholder image

Technology Transfer Funding Opportunity: SBIR Direct-to-Phase II Award

A new funding opportunity announcement (FOA) is available to move commercially viable diagnostic inventions from NIAID and NIDDK intramural research laboratories into the marketplace. This FOA solicits Small Business Innovation Research (SBIR) grant applications for projects that further develop and
More
blank new placeholder image

NIH OTT FY-2013 Annual Report Now Available

The OTT is pleased to announce that the annual report for Fiscal Year 2013 is now available for downloading. Click the icon below to download and view the report.
More
blank new placeholder image

NIH IRP Inventions Have High Public Health Impact

NIH-OTT authors report in Nature Biotechnology (Jan 2014) an analysis of FDA approved drugs and biologics that utilize inventions licensed from the NIH Intramural Research Program (IRP). Compared with other public-sector research institutions in the US, the NIH-IRP contribution has had a
More